date stringlengths 23 23 | title stringlengths 1 512 ⌀ | stock stringlengths 1 6 ⌀ |
|---|---|---|
2018-05-15 00:00:00 UTC | 25 Stocks Moving In Tuesday's Pre-Market Session | A |
2018-05-14 00:00:00 UTC | 10 Stocks Moving In Monday's After-Hours Session | A |
2018-05-14 00:00:00 UTC | Agilent Technologies Shares Down 6.5% After Hours Following Mixed Q2 Results; Co. Reaffirmed Downbeat Q3 And FY18 Guidance Estimates | A |
2018-05-14 00:00:00 UTC | Agilent Technologies Reaffirms FY2018 EPS ~$2.65 vs $2.70 Est., Core Sales Growth 5.5% | A |
2018-05-14 00:00:00 UTC | Agilent Technologies Sees Q3 EPS $0.61-0.63 vs $0.65 Est; Sees Sales $1.19B-1.21B vs $1.21B Est | A |
2018-05-14 00:00:00 UTC | Agilent Technologies Q2 EPS $0.65 Beats $0.64 Estimate, Sales $1.206B Miss $1.21B Estimate | A |
2018-05-14 00:00:00 UTC | The Week Ahead: Coindesk Conference, Walmart And Retailers Close Out Earnings Season | A |
2018-05-14 00:00:00 UTC | 7 Stocks To Watch For May 14, 2018 | A |
2018-05-14 00:00:00 UTC | Earnings Scheduled For May 14, 2018 | A |
2018-05-02 00:00:00 UTC | Agilent Reports Purchase Of Genohm, No Terms Disclosed | A |
2018-04-18 00:00:00 UTC | Agilent Technologies Files Second Civil Action Against Changzhou Pannatek to 'Protect Intellectual Property' | A |
2018-04-11 00:00:00 UTC | Morgan Stanley Maintains Overweight on Agilent Technologies, Lowers Price Target to $91.00 | A |
2018-04-03 00:00:00 UTC | UPDATE: Alnylam, Agilent Deal Has Initial Term Of 5 Years, With Automatic Renewal Terms OF 2 Years Absent Earlier Termination, No Further Terms Disclosed | A |
2018-04-03 00:00:00 UTC | Alnylam Pharma 8-K Shows Co. Entered Manufacturing Services Deal With Agilent For Providing Of Commercial Supply Of Patisiran | A |
2018-04-03 00:00:00 UTC | Agilent Technologies Signs Agreement To Acquire Lasergen For $105M | A |
2018-03-07 00:00:00 UTC | Agilent Technologies to Acquire Advanced Analytical Technologies for $250M in Cash | A |
2018-02-15 00:00:00 UTC | Bank Of America Out Positive On Agilent, Raises Price Target From $80 To $83 As Frim Says Core Business Continues To Do Well, Led By C&E Strength And Pharma; Remains A Focus Stock For Bank of America | A |
2018-02-15 00:00:00 UTC | JP Morgan Maintains Overweight on Agilent Technologies Inc, Raises price target to $80.00 | A |
2018-02-14 00:00:00 UTC | Agilent Sees Q2 Adj. EPS $0.61-$0.63 vs $0.64 Est., Sales $1.2B-$1.22B vs $1.17B Est.; FY18 Adj. EPS $2.62-$2.68 vs $2.59 Est., Sales $4.885B-$4.905B vs $5.04B Est. | A |
2018-02-14 00:00:00 UTC | Agilent Reports Q1 Adj. EPS $0.66 vs $0.58 Est., Sales $1.21B vs $1.16B Est. | A |
2018-02-14 00:00:00 UTC | Earnings Scheduled For February 14, 2018 | A |
2018-02-13 00:00:00 UTC | Phillips 66 Says it Has Agreed to Repurchase 35M Shares of Phillips 66 Common Stock from Wholly-owned Subsidiary of Berkshire Hathaway | A |
2018-01-29 00:00:00 UTC | Agilent Reports Scientific Partnership with the University of Southern California | A |
2018-01-23 00:00:00 UTC | The 10 Most Expensive Stocks In The S&P 500 | A |
2018-01-09 00:00:00 UTC | JP Morgan Healthcare Conference Continues Today, Presenters Include: Bluebird Bio, Agilent, Insulet, Cigna, DexCom, Eli Lilly, LifePoint, Acadia, Alkermes, Juno Therapeutics | A |
2018-01-09 00:00:00 UTC | Agilent Reports Purchase Of Luxcel Biosciences, No Terms Disclosed | A |
2018-01-04 00:00:00 UTC | Evercore ISI Group Initiates Coverage On Agilent Technologies with Outperform Rating, Announces $75.00 Price Target | A |
2018-01-04 00:00:00 UTC | Goldman Sachs Healthcare CEOs Unscripted Conference Taking Place Today; Presenters Include Agilent, Bluebird Bio, Boston Scientific, Alexion, Eli Lilly, and Alnylam | A |
2017-12-08 00:00:00 UTC | Aquinox Pharmaceuticals Announces FDA Panel Voted 15 to 0 That Patients With Interstitial Cystitis and Patients With Bladder Pain Syndrome Should Be Combined in Clinical Trials | A |
2017-11-21 00:00:00 UTC | Deutsche Bank Says Agilent Can Be The Next 'Compounder' In The Life Science Tools & Diagnostics Space Based On Product Cycles, Margin Expansion Opportunities, and Balanced End Market Exposures | A |
2017-11-21 00:00:00 UTC | 33 Stocks Moving In Tuesday's Pre-Market Session | A |
2017-11-21 00:00:00 UTC | 14 Stocks To Watch For November 21, 2017 | A |
2017-11-20 00:00:00 UTC | 7 Stock's Moving In Monday's After-Hours Session | A |
2017-11-20 00:00:00 UTC | Agilent Sees Q1 Adj. EPS $0.55-$0.57 vs $0.60 Est., Sales $1.145B-$1.165B vs $1.15B Est. | A |
2017-11-20 00:00:00 UTC | Agilent Sees FY18 Adj. EPS $2.50-$2.56 vs $2.59 Est., Sales $4.72B-$4.74B vs $4.73B Est. | A |
2017-11-20 00:00:00 UTC | Agilent Reports Q4 Adj. EPS $0.67 vs $0.62 Est., Sales $1.19B vs $1.17B Est. | A |
2017-11-20 00:00:00 UTC | 7 Stocks To Watch For November 20, 2017 | A |
2017-11-20 00:00:00 UTC | Earnings Scheduled For November 20, 2017 | A |
2017-11-15 00:00:00 UTC | Agilent Raises Qtr. Dividend From $0.13/Share To $0.149/Share | A |
2017-11-14 00:00:00 UTC | Morgan Stanley Maintains Overweight on Agilent Technologies, Raises Price Target to $88.00 | A |
2017-09-22 00:00:00 UTC | Agilent Technologies Receives FDA Approval For Use Of Dako PD-L1 For Treatment With Merck's KEYTRUDA In Gastric or Gastroesophageal Junction Cancer | A |
2017-09-19 00:00:00 UTC | Agilent Reports Dako PD-L1 IHC 28-8 PharmDx Approved For 2 New Indications: Urothelial Carcinoma, Squamous Cell Carcinoma Of Head And Neck | A |
2017-09-13 00:00:00 UTC | Agilent Reports FDA Approval Of GenetiSure Dx Postnatal Assay | A |
2017-08-23 00:00:00 UTC | Agilent Files Civil Lawsuit against Shanghai Echrom Electronic Technology Co. | A |
2017-08-16 00:00:00 UTC | 12 Biggest Mid-Day Gainers For Wednesday | A |
2017-08-16 00:00:00 UTC | 3 Things Deutsche Bank Likes About Agilent's Q3, And One Thing To Be Cautious Of | A |
2017-08-16 00:00:00 UTC | 5 Things That Stood Out In Another Beat And Raise Quarter From Agilent | A |
2017-08-16 00:00:00 UTC | 20 Stocks Moving In Wednesday's Pre-Market Session | A |
2017-08-16 00:00:00 UTC | A Peek Into The Markets: U.S. Stock Futures Rise; All Eyes On Fed Minutes | A |
2017-08-16 00:00:00 UTC | 8 Stocks To Watch For August 16, 2017 | A |
2017-08-15 00:00:00 UTC | Agilent Sees Q4 Adj. EPS $0.60-$0.62 vs $0.60 Est., Sales $1.15B-$1.17B vs $1.15B Est.; FY17 Adj. EPS $2.29-$2.31 vs $2.23 Est., Sales $4.435B-$4.455B vs $4.41B Est. | A |
2017-08-15 00:00:00 UTC | Agilent Technologies Reports Q3 Adj. EPS $0.59 vs $0.52 Est., Sales $1.11B vs $1.09B Est. | A |
2017-08-15 00:00:00 UTC | 10 Stocks To Watch For August 15, 2017 | A |
2017-08-15 00:00:00 UTC | Earnings Scheduled For August 15, 2017 | A |
2017-07-24 00:00:00 UTC | Agilent Acquires Powerful Next Gen Sequencing IP Portfolio, No Terms Disclosed | A |
2017-07-13 00:00:00 UTC | Wells Fargo Upgrades Agilent Technologies to Outperform | A |
2017-07-07 00:00:00 UTC | Agilent Reports Purchase Of Cobalt Light Systems For £40M In Cash | A |
2017-06-28 00:00:00 UTC | Unisys ClearPath Software Selected by Malaysia's ANGKASA | A |
2017-06-23 00:00:00 UTC | Why Agilent Technologies (A) Stock Might be a Great Pick | A |
2017-06-23 00:00:00 UTC | Why Agilent Technologies (A) Stock Might be a Great Pick | A |
2017-06-19 00:00:00 UTC | All Mixed Up | A |
2017-06-14 00:00:00 UTC | Goldman Sachs Global Healthcare Conference Continues Today, Presenters Include: Agilent, Sage Therapeutics, and GW Pharmaceuticals | A |
2017-06-08 00:00:00 UTC | Unisys Launches FamilyNow for Aiding Social Service Agencies | A |
2017-06-06 00:00:00 UTC | Jefferies Health Care Conference Begins Today, Presenters Include: Agilent Technologies, Civitas Solutions, Aeri Pharmaceuticals, Alkermes, Alnylam Pharmaceuticals, Heron Therapeutics | A |
2017-06-02 00:00:00 UTC | Agilent Reports Deal with Agendia for Molecular Cancer Diagnostics | A |
2017-05-30 00:00:00 UTC | Agilent Spikes to High of $60.40 on Volume | A |
2017-05-23 00:00:00 UTC | 15 Biggest Mid-Day Gainers For Tuesday | A |
2017-05-23 00:00:00 UTC | Agilent Technologies Sharply Higher After Q2 Beat | A |
2017-05-23 00:00:00 UTC | 5 Biggest Price Target Changes For Tuesday | A |
2017-05-23 00:00:00 UTC | 20 Stocks Moving In Tuesday's Pre-Market Session | A |
2017-05-23 00:00:00 UTC | A Peek Into The Markets: U.S. Stock Futures Gain Ahead Of Economic Reports | A |
2017-05-23 00:00:00 UTC | 8 Stocks To Watch For May 23, 2017 | A |
2017-05-22 00:00:00 UTC | UPDATE: Agilent Raises FY17 Adj. EPS Outlook to $2.15-$2.21 vs $2.16 Est., Sales to $4.36B-$4.38B vs $4.35B Est. | A |
2017-05-22 00:00:00 UTC | Agilent Sees Q3 Adj. EPS $0.49-$0.51 vs $0.53 Est., Sales $1.06B-$1.08B vs $1.08B Est. | A |
2017-05-22 00:00:00 UTC | Agilent Raises FY Outlook | A |
2017-05-22 00:00:00 UTC | Agilent Reports Q2 Adj. EPS $0.58 vs $0.48 Est., Sales $1.1B vs $1.05B Est. | A |
2017-05-22 00:00:00 UTC | 5 Stocks To Watch For May 22, 2017 | A |
2017-05-22 00:00:00 UTC | Earnings Scheduled For May 22, 2017 | A |
2017-03-31 00:00:00 UTC | 7 Biggest Price Target Changes For Friday | A |
2017-03-15 00:00:00 UTC | Agilent Names Koh Boon Hwee Chair | A |
2017-03-15 00:00:00 UTC | 18 Biggest Mid-Day Gainers For Wednesday | A |
2017-03-15 00:00:00 UTC | Benzinga's Top Upgrades, Downgrades For March 15, 2017 | A |
2017-03-15 00:00:00 UTC | Morgan Stanley Upgrades Agilent Technologies To Overweight | A |
2017-03-13 00:00:00 UTC | The Technician's Playbook: 11 Sector Pair Trades | A |
2017-03-08 00:00:00 UTC | Cowen Annual Healthcare Conference Concludes Today; Presenters Include Agilent Tech, Incyte, GW Pharma, Teva Pharma, NantKwest, Seattle Genetics, And Celgene | A |
2017-02-15 00:00:00 UTC | 5 Biggest Price Target Changes For Wednesday | A |
2017-02-14 00:00:00 UTC | Agilent Raises FY17 Outlook | A |
2017-02-14 00:00:00 UTC | Agilent Reports Q1 Adj. EPS $0.53 vs $0.49 Est., Sales $1.07B vs $1.05B Est. | A |
2017-02-14 00:00:00 UTC | Earnings Scheduled For February 14, 2017 | A |
2017-01-18 00:00:00 UTC | Deutsche Bank Optimistic On Fundamentals In Life Science Tools/Diagnostics Sector | A |
2017-01-11 00:00:00 UTC | Hearing Thermo Fisher In Talks To Buy Agilent | A |
2017-01-04 00:00:00 UTC | 7 Biggest Price Target Changes For Wednesday | A |
2017-01-04 00:00:00 UTC | Benzinga's Top Upgrades, Downgrades For January 4, 2017 | A |
2017-01-04 00:00:00 UTC | Barclays Upgrades Agilent Technologies to Overweight, Raises Target to $51.00 | A |
2016-12-20 00:00:00 UTC | Agilent to Buy Multiplicom for €68M in Cash | A |
2016-12-06 00:00:00 UTC | Pressure Biosciences CEO On Its Beaten Down Stock: 'We Can Now Begin To Focus On The Area That Is Most Important' | A |
2016-11-16 00:00:00 UTC | The Market In 5 Minutes: DryShips, Trump And Target | A |
2016-11-16 00:00:00 UTC | A Peek Into The Markets: U.S. Stock Futures Decline Ahead Of Economic Data | A |
2016-11-16 00:00:00 UTC | Keep an Eye on These 8 Stocks for November 16, 2016 | A |
2016-11-15 00:00:00 UTC | Agilent Technologies Sees FY17 Rev. $4.35B-$4.37B vs. Est. $4.35B, EPS $2.10-$2.16 vs. Est. $2.19; Q4 Rev. $1.04-$1.04B vs. Est. $1.08B, EPS $0.48-$0.50 vs. Est. $0.53 | A |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.